SEC Form 4 · accession 0001104659-18-073106
BioXcel Therapeutics, Inc. · BTAI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vimal Mehta
Officer — CEO, President, Secretary · Director
Period of report
Dec 14, 2018
Accepted (ET)
Dec 14, 2018 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001720893
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 14, 2018 | P | 800 | $4.27 | A | 3,800 | D | |
| Common Stock | Dec 14, 2018 | P | 200 | $4.32 | A | 4,000 | D | |
| Common Stock | Dec 14, 2018 | P | 500 | $4.48 | A | 4,500 | D | |
| Common Stock | Dec 14, 2018 | P | 400 | $4.49 | A | 4,900 | D | |
| Common Stock | Dec 14, 2018 | P | 100 | $4.50 | A | 5,000 | D |
Table II — derivative securities
No Table II lines on this filing.